NDC 59262-272

Ear Wax Relief

Causticum, Graphite, Lachesis Muta Venom And Lycopodium Clavatum Spore

Ear Wax Relief is a Auricular (otic) Solution in the Human Otc Drug category. It is labeled and distributed by Similasan Corporation. The primary component is Causticum; Graphite; Lachesis Muta Venom; Lycopodium Clavatum Spore.

Product ID59262-272_3470eb8c-9fe4-43a8-82ab-29ebc65f0b11
NDC59262-272
Product TypeHuman Otc Drug
Proprietary NameEar Wax Relief
Generic NameCausticum, Graphite, Lachesis Muta Venom And Lycopodium Clavatum Spore
Dosage FormSolution
Route of AdministrationAURICULAR (OTIC)
Marketing Start Date2003-06-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameSimilasan Corporation
Substance NameCAUSTICUM; GRAPHITE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE
Active Ingredient Strength12 [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL
NDC Exclude FlagN
Listing Certified Through2024-12-31

Packaging

NDC 59262-272-11

10 mL in 1 BOTTLE, DROPPER (59262-272-11)
Marketing Start Date2003-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59262-272-11 [59262027211]

Ear Wax Relief SOLUTION
Marketing CategoryUNAPPROVED HOMEOPATHIC
Product TypeHUMAN OTC DRUG
Billing UnitML
Marketing Start Date2003-06-01
Inactivation Date2020-01-31
Reactivation Date2020-04-15

Drug Details

Active Ingredients

IngredientStrength
CAUSTICUM12 [hp_X]/10mL

OpenFDA Data

SPL SET ID:1b548338-f9f0-4a63-b553-df4fcd18d594
Manufacturer
UNII
UPC Code
  • 0094841255156

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.